Efficacy of Sublingual Immunotherapy in Allergic Rhinitis Children during Coronavirus Disease 20192019년 코로나바이러스 질병 기간 동안 알레르기성 비염 소아에서 설하 면역요법의 효능Article Published on 2021-01-012022-09-11 Journal: ORL; journal for oto-rhino-laryngology and its rel [Category] 치료기술, [키워드] activity Adverse reaction Adverse reactions allergen allergic rhinitis baseline level baseline levels change children clinical effectiveness coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 different time point different time points disease effective Effectiveness evaluate evaluated family had more had no house House dust House dust mite IgE Immunotherapy medication nasal no significant differences Occurrence recruited reduced reduction restrict rhinitis serum significant differences significantly significantly lower SLIT Sublingual Sublingual immunotherapy Symptom the epidemic Total Total nasal symptoms score. Treatment [DOI] 10.1159/000514157 PMC 바로가기 [Article Type] Article
Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential폐약물 전달 시스템과 특발성 폐섬유증을 결합한 한의학: 이론적 근거와 치료 가능성Review Published on 2021-01-012022-08-31 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] MERS, 치료제, [키워드] Adverse reaction Adverse reactions approach article Bioavailability Chinese CNKI coronavirus disease Coronavirus disease 2019 COVID-19 diarrhoea drug drug delivery system drugs effective etiology FDA Google Scholar identify idiopathic Idiopathic pulmonary fibrosis IMPROVE inflammatory disease ingredient intake interstitial IPF Medicine metabolism nausea Nintedanib overcome Pirfenidone problem pulmonary Pulmonary drug delivery system pulmonary fibrosis rationale reduce Research retrieved Safe sequela Severe patient severe patients Side effect Support TCM therapeutic drug therapeutic potential Traditional Traditional Chinese medicine treat Treatment unique Web of Science [DOI] 10.1016/j.biopha.2020.111072 PMC 바로가기 [Article Type] Review
Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials무작위 대조 시험에서 이상 반응 정보를 평가하고 전달하기 위한 시각화의 장점Research Published on 2020-12-222022-09-10 Journal: Trials [Category] 임상, 치료제, [키워드] adverse event adverse events Adverse reactions AEs Analysis article asymmetry collected communication comparison complex construction Controlled trial controlled trials COVID-19 Data analysis effective evaluate event extreme Frequency GDNF Graphics Guidance harms implementation in some information investigator investigators lack less offer outcome Parkinson disease Parkinson’s disease Placebo-controlled trials point estimate point estimates profile Prominent provided randomised controlled trial Randomised controlled trials RCTs Remdesivir Reporting risk shown Stata statistical supplementary material Support treatment effect treatment effects Trial trials Visual Visualisation volcano plot Volume [DOI] 10.1186/s13063-020-04903-0 PMC 바로가기 [Article Type] Research
Identifying side effects of commonly used drugs in the treatment of Covid 19Covid 19 치료에 일반적으로 사용되는 약물의 부작용 식별Review Published on 2020-12-092022-09-10 Journal: Scientific Reports [Category] MERS, SARS, 임상, 치료기술, 치료법, 치료제, [키워드] addition Adverse reaction Adverse reactions Atazanavir cardiovascular system caused clinical study COVID-19 treatment drug Drug safety drug-drug interaction Drug-drug interactions drugs drugs in combination estimate experimental results experiments facilitate graph hematopoietic system heparin identifying information technology Interaction other organs Patient patients produced Side effect Side effects Treatment [DOI] 10.1038/s41598-020-78697-1 PMC 바로가기 [Article Type] Review
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongationArticle Published on 2020-12-012022-10-04 Journal: Chemico-biological interactions [Category] SARS, 신약개발, [키워드] absence administration Adverse adverse event Adverse reactions affecting AKT1 Algorithm Azithromycin cardiac Cardiac arrhythmia Combination Complete Consensus correlation Coverage COVID-19 COVID-2019 database drug drug combination drug target drug targets effective ERBB2 Final HCQ HSP90AA1 hub protein Hydroxychloroquine implication Interaction involved limitation network network pharmacology node degree pandemic pathway patients performed Protein QT interval reached reduce risk screened subsequent System target therapeutic option Treatment VEGF [DOI] 10.1016/j.cbi.2020.109299 PMC 바로가기 [Article Type] Article
Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infectionSARS-CoV-2 감염 치료에 특별히 사용되는 약물의 부작용Review Published on 2020-11-272022-09-11 Journal: Medicina clínica [Category] 치료제, [키워드] Adverse Adverse drug reaction Adverse drug reactions adverse effect Adverse reaction Adverse reactions Alergia a medicamento allergy approved COVID-19 COVID-19 treatment described disease drug Drug allergy drug reaction Efficacy and safety healthcare worker Healthcare workers hospital immunological Infection Inflammatory response initial Numerous pandemic pharmacovigilance Program Reacción adversa a medicamento Registered SARS-CoV-2 SARS-COV-2 infection the SARS-CoV-2 thought Tratamiento COVID-19. Treatment Viral viral infection [DOI] 10.1016/j.medcli.2020.06.019 PMC 바로가기 [Article Type] Review
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug AdministrationArticle Published on 2020-10-312024-08-30 Journal: Archives of Dermatological Research [Category] 백선증, [키워드] adverse events Adverse reactions ciclopirox efinaconazole FAERS FDA Google Google Trends Jublia Kerydin Nail discoloration Onychomycosis Penlac tavaborole PMC 바로가기
Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID‐19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case seriesShort Report Published on 2020-10-232022-10-28 Journal: Virology Journal [Category] COVID-19, MERS, SARS, [키워드] accelerate Adverse reactions affecting age antiviral drug Arbidol basic case sery clinical Clinical characteristics conditions contributed coronavirus disease COVID-19 COVID-19 cohort COVID-19 patient COVID‐19 patient described disease Effect Efficacy Efficiency evaluate evaluated Factor feature females Fever Gender higher risk hospital Hospital stay Infectious disease male males maximum body temperature Mild objective Patient patients respiratory specimens Result retrospective SARS-CoV-2 Symptom viral clearance [DOI] 10.1186/s12985-020-01428-5 PMC 바로가기 [Article Type] Short Report
Reduning injection combined with western medicine for pneumonia A protocol for systematic review and meta-analysis3800 Published on 2020-10-232022-10-30 Journal: Medicine [Category] COVID-19, MERS, SARS, [키워드] absorbed Adverse reactions affected bias risk cardiovascular disease caused CBM Chinese Chongqing CNKI Cochrane Library Combination data extraction database effective Efficacy Efficacy and safety Ethical approval Ethics evaluated Evidence Health incidence induce Infrastructure injection Injections life-threatening literature Man Meta-analysis Mortality New coronavirus performed Pneumonia protocol provide rale RCT Reduning injection Registration required Research Respiratory disease retrieved review risk of bia SARS-CoV-2 Science severe cases significantly Support systematic review TCM technology the patient treat treated Treatment VIP was used Web of Science X-ray [DOI] 10.1097/MD.0000000000022757 PMC 바로가기 [Article Type] 3800
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial이중 맹검, 무작위, 위약 대조 임상 3상 임상 시험을 통해 의료 전문가를 Sinovac에서 제조한 흡착된 COVID-19(불활성화) 백신으로 치료하는 효과와 안전성을 평가합니다. – PROFISCOV: 무작위 대조를 위한 연구 프로토콜의 구조화된 요약 재판Letter Published on 2020-10-152022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] 95% confidence interval Active surveillance adjuvant Administered administration Adults adverse event adverse events Adverse reaction Adverse reactions age Aluminium aluminium hydroxide Analysis attack rate Beijing blind Blinding Brazil Breastfeeding calculated Care causal relationship China clinical clinical care clinically Committee completion confirmed case Consent consent form Contact contact with Control COVID-19 criterion database defined Diagnosis direct contact disease dissemination dose double-blind double-blind study Efficacy Efficacy and safety elderly element Endpoint evaluate exclusion criteria expected experimental intervention FDA form Frequency genders Health Health Organization hydroxide immunogenicity inactivated Inactivated Vaccines incidence include Inclusion information Informed intramuscular dose life limit Local monitoring multicenter nucleic acid number Nurse Nurses objective Occurrence Older outcome participant Participants Participation Patient phase Phase III Clinical Trial Placebo placebo-controlled clinical trial pregnant pregnant women primary efficacy endpoint produced product professional professionals protocol randomisation randomised randomised controlled trial randomization randomization list randomization system Randomized receive recruitment regimen registry responsible retained Safety Sample size SARS-CoV-2 nucleic acid SARS-CoV-2 virus schedule second vaccination separation Sinovac Sinovac Life Science Sinovac Life Sciences Sponsor status stratified Study protocol subjects symptomatic case symptomatic cases symptomatic individuals systemic adverse reaction systemic adverse reactions the vaccine threshold Trial Trial registration undergo vaccination Vaccine Virological voluntary website World Health Organization [DOI] 10.1186/s13063-020-04775-4 PMC 바로가기 [Article Type] Letter